Document Detail

The effect of exercise on serum levels of interleukin-18 and components of the metabolic syndrome.
MedLine Citation:
PMID:  19900154     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: There is increasing evidence that the metabolic syndrome is associated with a proinflammatory state. Interleukin-18 (IL-18) has been shown to be associated with multiple components of the syndrome and to predict the development of diabetes and cardiovascular events. The aim of the present work was to investigate if exercise could reduce serum levels of IL-18 in subjects with the metabolic syndrome, and if potential changes would be associated with changes in body composition and components of the syndrome. Pravastatin was used for comparison. METHODS: We investigated the effect of 12 weeks of intervention with exercise, pravastatin, or both on serum levels of IL-18 in 34 subjects with the metabolic syndrome. RESULTS: Levels of IL-18 were reduced by exercise (P = 0.036), pravastatin (P = 0.036), and the combination (P = 0.017) versus baseline, however without intergroup differences. Still, the reduction in the exercise group was not negligible (17.5%). Furthermore, reduced levels of IL-18 were significantly associated with improvement of an increasing number of components of the metabolic syndrome (P = 0.034). This effect is likely to be caused by exercise, because this intervention had a beneficial effect on components of the syndrome compared to the control group (P = 0.029). CONCLUSIONS: Our findings suggest that the protective effect of exercise might be due in part to reduced inflammation associated with improvement of the metabolic syndrome and its components. Studies with larger sample sizes are warranted to confirm this hypothesis.
Marius Tr?seid; Knut T Lappeg?rd; Tom E Mollnes; Harald Arnesen; Ingebj?rg Seljeflot
Related Documents :
10573494 - Effect of cholesterol lowering treatment on positive exercise tests in patients with hy...
1764814 - Acute effects of exercise on plasma lipids, noradrenaline levels and plasma volume.
18805104 - Predictors of endothelial function in employees with sedentary occupations in a worksit...
15179164 - Apolipoprotein c-iii ssti genotypes modulate exercise-induced hypotriglyceridemia.
12324544 - Heart rate and the rate of oxygen consumption of flying and walking barnacle geese (bra...
3388444 - Comparative dermal carcinogenesis of shale and petroleum-derived distillates.
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Metabolic syndrome and related disorders     Volume:  7     ISSN:  1557-8518     ISO Abbreviation:  Metab Syndr Relat Disord     Publication Date:  2009 Dec 
Date Detail:
Created Date:  2009-12-21     Completed Date:  2010-03-04     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101150318     Medline TA:  Metab Syndr Relat Disord     Country:  United States    
Other Details:
Languages:  eng     Pagination:  579-84     Citation Subset:  IM    
Center for Clinical Heart Research, Department of Cardiology, Oslo University Hospital, Ullev?l, Oslo, Norway.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cardiovascular Diseases / prevention & control
Combined Modality Therapy
Exercise Therapy*
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
Inflammation Mediators / blood
Interleukin-18 / blood*
Metabolic Syndrome X / blood*,  drug therapy,  therapy*
Middle Aged
Pravastatin / therapeutic use
Reg. No./Substance:
0/Hydroxymethylglutaryl-CoA Reductase Inhibitors; 0/Inflammation Mediators; 0/Interleukin-18; 81093-37-0/Pravastatin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The Metabolic Syndrome in South Asians: Epidemiology, Determinants, and Prevention.
Next Document:  Yoga Practice in Diabetes Improves Physical and Psychological Outcomes.